UNOMR AG, a techBio startup from ETH Zurich, is developing next-generation protein sensors to solve one of the biggest blind spots in modern biology and medicine: our inability to fully read and understand proteins.
Envisioning single-molecule protein sequencing through their innovative interface nanopore sensor, UNOMR currently focuses on protein glycosylation occupancy on a single molecule level.
Our goal is to enable every lab to read proteins as easily as DNA is read today and transform protein sequencing from a complex research challenge into a practical and scalable tool for pharma, biotech, food innovation, and academia to catalyse the next breakthrough in precision medicine.
08.06.2026
Venture Leaders Biotech Roadshow 2026: Swiss biotech startups connect with US investors in Boston (venturelab.swiss)
28.05.2026
Eight Swiss startups receive international recognition (startupticker.ch)
18.03.2026
Ten Swiss biotech startups selected for Boston roadshow (startupticker.ch)
18.03.2026
Venture Leaders Biotech 2026: 10 innovative biotech startups selected for the Boston roadshow (venturelab.swiss)
14.04.2025
UNOMR gets CHF 150,000 from Venture Kick to bring a new dimension to proteomics analysis (venturekick.ch)
27.02.2026
Pre-seed closed
05.01.2026
Start of SPRIN-D project
11.08.2025
15.02.2025
Innobooster funding
16.12.2024
Innosuisse funding received
No Jobs
VentureKick presentation
Venture Kick supports potential entrepreneurs with start capital up to CHF 150'000 as well as hands-on execution support and access to a nationwide network of investors and experts in the startup field. Multiple times per year, 8 selected projects get the opportunity to present their business ideas in front of a panel. The 5 most promising projects enter the support process. After 9 months at the latest, the startups incorporate and enter the market. Since 2007, Venture Kick has invested over CHF 58 million in over 1111 projects.
Website:
www.unomr.com
Headquarter:
Zurich
Foundation Date:
August 2025
Technology:
Sectors: